ardeparin
Trade name: normiflo
Small moleculeapproved
Approved
Nov 7, 1997
Ardeparin is an anticoagulant. It was used for the prevention of deep vein thrombosis, but was withdrawn from the US market in 2000 for reasons unrelated to safety or efficacy. — Wikipedia
Clinical trial activity
0 trials · 0 clinical orgs · 2 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1990s
- May 1, 1997
American Home Products — First NDA Organization
- May 1, 1997
American Home Products — NDA Organization
- Nov 7, 1997
Earliest FDA Approval
Indications
Mechanism of action
- Antithrombin-IIIACTIVATOR
SERPINC1 activator
Inhibits coagulation by activating antithrombin III; ATIII then binds to F10; It's a low-molecular-weight heparin
Approval history
- approvedNov 7, 1997
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Discontinued
Oral
No
Parenteral
Yes
Topical
No
Sources
- WikipediaArdeparin ↗
- NCATSVL0L558GCB ↗
- ChEMBLCHEMBL1201448 ↗
- WikipediaArdeparin sodium ↗
Also known as
- ardeparin
- ardeparin
- ardeparin
- ardeparin
- ardeparin
- ardeparin sodium
- ardeparin sodium
- ardeparin sodium
- ardeparin sodium
- normiflo
- normiflo
- normiflo
- normiflo
- wy-90493 rd
Organizations
Marketing (2)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| American Home Products | For profit | NDA | May 1, 1997 |
| Pharmacia & Upjohn | For profit | NDA2 | — |